Omeros (OMER) Tax Provisions (2020 - 2026)
Omeros recorded quarterly Tax Provisions of $57000.0 in Q1 2026, up 100.37% quarter-over-quarter from -$15.4 million in Q4 2020.
Omeros' Tax Provisions history runs 2 years deep, the most recent figure standing at $57000.0 for Q1 2026.
- In Q1 2026, Tax Provisions changed N/A year-over-year to $57000.0; the TTM figure through Mar 2026 stood at -$23.2 million (changed N/A YoY), while the FY2025 annual figure was $2.0 million, down 12.71% from the prior year.
- Tax Provisions came in at $57000.0 for Q1 2026 at Omeros, up from -$15.4 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $57000.0 in Q1 2026 to a low of $57000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,000.00 |
| Dec 31, 2020 | -15.45 Mn |
| Sep 30, 2020 | -7.85 Mn |